These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32629542)

  • 1. Immunocompromised cutaneous district, isotopic, and isopathic phenomena-Systematic review.
    Tabosa GVBS; Stelini RF; Souza EM; Velho PENF; Cintra ML; Florence MEB
    J Cosmet Dermatol; 2021 Feb; 20(2):410-416. PubMed ID: 32629542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ruocco's immunocompromised cutaneous district.
    Piccolo V; Baroni A; Russo T; Schwartz RA
    Int J Dermatol; 2016 Feb; 55(2):135-41. PubMed ID: 26475059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocompromised Districts of Skin: A Case Series and a Literature Review.
    Vojvodic A; Tirant M; Nardo VD; Lotti T; Wollina U
    Open Access Maced J Med Sci; 2019 Sep; 7(18):2969-2975. PubMed ID: 31850101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Necrobiosis lipoidica developing within a surgical scar in a non-diabetic patient: Type III Koebner phenomenon (isomorphic response), Wolf's isotopic response or Ruocco's immunocompromised cutaneous district?
    Prieto-Torres L; Bernárdez C; Hernández-Ostiz S; Pastushenko I; Ara-Martin M; Requena L
    Indian J Dermatol Venereol Leprol; 2017; 83(2):233-236. PubMed ID: 28071608
    [No Abstract]   [Full Text] [Related]  

  • 5. Zosteriform impetigo: Wolf's isotopic response in a cutaneous immunocompromised district.
    Cohen PR
    Dermatol Pract Concept; 2015 Jul; 5(3):35-9. PubMed ID: 26336623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wolf's isotopic response: The first attempt to introduce the concept of vulnerable areas in dermatology.
    Wolf R; Wolf D; Ruocco V; Ruocco E
    Clin Dermatol; 2014; 32(5):557-60. PubMed ID: 25160096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isomorphic sclerotic-type cutaneous chronic graft-versus-host disease: report and review of chronic graft-versus-host disease in a cutaneous immunocompromised district.
    Cohen PR
    Dermatol Ther (Heidelb); 2013 Dec; 3(2):215-22. PubMed ID: 24318412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulomatous dermatitis as a postherpetic isotopic response in immunocompromised patients: A report of 5 cases.
    McCoy WH; Otchere E; Musiek AC; Anadkat MJ
    JAAD Case Rep; 2018 Sep; 4(8):752-760. PubMed ID: 30246119
    [No Abstract]   [Full Text] [Related]  

  • 9. [Köbner, Renbök, Wolf phenomena and so on… has the time come for simplification?].
    Kluger N
    Ann Dermatol Venereol; 2018 May; 145(5):347-353. PubMed ID: 29673749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical Cutaneous Presentations of Sarcoidosis: Two Case Reports and Review of the Literature.
    Leverenz DL; Henderson C; Shah A
    Curr Allergy Asthma Rep; 2018 Jun; 18(8):40. PubMed ID: 29904803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunocompromised district: a unifying concept for lymphoedematous, herpes-infected and otherwise damaged sites.
    Ruocco V; Brunetti G; Puca RV; Ruocco E
    J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1364-73. PubMed ID: 19548975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Extra-facial Lever granuloma on a herpes zoster scar: Wolf's isotopic response].
    Melgar E; Henry J; Valois A; Dubois-Lacour MB; Truchetet F; Cribier B; Cuny JF
    Ann Dermatol Venereol; 2018 May; 145(5):354-358. PubMed ID: 29673750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lichen Sclerosus on the Sites of Striae Distensae and a Surgical Scar in a Patient with Coexistent Morphea.
    Baykal C; Kobaner GB; Copur S; Buyukbabani N
    Acta Dermatovenerol Croat; 2019 Mar; 27(1):44-46. PubMed ID: 31032793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wolf's Isotopic Response after Herpes Zoster Infection: A Study of 24 New Cases and Literature Review.
    Wang T; Zhang M; Zhang Y; Zhang Y; Zhang S; Qu T; Liu Y; Jin H
    Acta Derm Venereol; 2019 Oct; 99(11):953-959. PubMed ID: 31321443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunistic localization of skin lesions on vulnerable areas.
    Ruocco V; Ruocco E; Brunetti G; Sangiuliano S; Wolf R
    Clin Dermatol; 2011; 29(5):483-8. PubMed ID: 21855722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Ruocco's hypothesis on immunocompromised cutaneous area potentiate the early surgical removal of cutaneous benign lesions as adequate prevention?
    Tchernev G; Temelkova I
    J Biol Regul Homeost Agents; 2019; 33(6):1811-1813. PubMed ID: 31625346
    [No Abstract]   [Full Text] [Related]  

  • 17. A New Skin Manifestation at the Site of a Previously Healed Dermatosis: A Case of Wolf's Isotopic Response.
    Munir S; Abu-Jubara D; Abu-Jubara M; Antypas C; Petro-Sakuma C
    Cureus; 2020 Nov; 12(11):e11381. PubMed ID: 33312782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tridimensional Matryoshka Tattoo: An Important.
    Tammaro A; Iacovino C; Magri F; Capalbo A; Giordano D; Parisella Francesca R; Persechino S; Chello C; De Marco G
    Acta Dermatovenerol Croat; 2019 Sep; 27(3):198-199. PubMed ID: 31542068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wolf's isotopic response.
    Wolf R; Wolf D; Ruocco E; Brunetti G; Ruocco V
    Clin Dermatol; 2011; 29(2):237-40. PubMed ID: 21396564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eczema of recipient and donor skin graft sites: Another example of "Ruocco's immunocompromised district".
    Verma SB; Wollina U; Ruocco E; Ruocco V
    Dermatol Ther; 2019 Nov; 32(6):e13076. PubMed ID: 31452287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.